Literature DB >> 29875190

Higher Sensitivity of the recomLine Borrelia IgG Immunoblot Kit than of the Standard Lyme IgG Immunoblot Kit According to CDC Testing Criteria.

Kamran Kadkhoda1,2,3, Ainsley Gretchen4.   

Abstract

Keywords:  Lyme; immunoblot; serodiagnosis

Mesh：

Substances：

Year:  2018        PMID： 29875190      PMCID： PMC6062798          DOI： 10.1128/JCM.00527-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

2.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

3.  Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Authors:  F T Liang; A C Steere; A R Marques; B J Johnson; J N Miller; M T Philipp
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Western blotting in the serodiagnosis of Lyme disease.

Authors:  F Dressler; J A Whalen; B N Reinhardt; A C Steere
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

5.  Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface.

Authors:  Emir Hodzic; Sunlian Feng; Kimberly J Freet; Dori L Borjesson; Stephen W Barthold
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441
  5 in total
  2 in total

1.  Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.

Authors:  Maroun M Sfeir; Jennifer K Meece; Elitza S Theel; Dane Granger; Thomas R Fritsche; Allen C Steere; John A Branda
Journal:  J Clin Microbiol       Date:  2022-04-14       Impact factor: 11.677

2.  Under-Detection of Lyme Disease in Canada.

Authors:  Vett K Lloyd; Ralph G Hawkins
Journal:  Healthcare (Basel)       Date:  2018-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.